Shenghan Lai

Statistics

Publications

Citations

103

H-Index

Active since

2022

Affiliations

University of Maryland, Baltimore(Current)

Johns Hopkins Medicine

Johns Hopkins University

Shenghan Lai is an author at University of Maryland, Baltimore specializing in cardiology, cardiovascular disease, and proprotein convertase subtilisin/kexin type 9 inhibition.

Publications per year

2022–2023

Publications

Lipoprotein(a) concentrations in acute myocardial infarction patients are not indicative of levels at six month follow-up

Efthymios Ziogos, Michael Vavuranakis, Tarek Harb et al. · European Heart Journal Open · 2023 · 37 citations · Full text

Medicine, Cardiology, Internal Medicine +17

The Trajectory of Lipoprotein(a) During the Peri- and Early Postinfarction Period and the Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition

Michael Vavuranakis, Steven R. Jones, Efthymios Ziogos et al. · The American Journal of Cardiology · 2022 · 36 citations

Life Sciences, Biochemistry, Cardiology +13

Platelet activation and endothelial dysfunction biomarkers in acute coronary syndrome: the impact of PCSK9 inhibition

Efthymios Ziogos, Stephen P. Chelko, Tarek Harb et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 2023 · 30 citations · Full text

Medicine, Cardiology, Pharmacology +17

1–3 of 3